Xiling Jiang

4PUBLICATIONS
35CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMolecular medicineRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Oct 01, 2026
FDA Approval Summary: Epcoritamab with Lenalidomide and Rituximab for Relapsed or Refractory Follicular Lymphoma.

|Aug 19, 2025
FDA Approval Summary: Blinatumomab for the Treatment of B-Cell Precursor Acute Lymphoblastic Leukemia in the Consolidation Phase of Multiphase Chemotherapy.

Cara A Rabik, Shu Wang, Ritu Chadda

|Oct 30, 2024
FDA Approval Summary: Olutasidenib for Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia with an Isocitrate Dehydrogenase 1 Mutation.

Ashley C Woods, Kelly J Norsworthy, Moran Choe

|Nov 27, 2023
FDA Approval Summary: Ivosidenib in Combination with Azacitidine for Treatment of Patients with Newly Diagnosed Acute Myeloid Leukemia with an IDH1 Mutation.

Ashley Woods, Kelly J Norsworthy, Xin Wang

Pageof 1

Frequent Collaborators

4 joint publications

R Angelo de Claro

3 joint publications

Jonathon Vallejo

3 joint publications

Marc R Theoret

2 joint publications

Ashley Woods